Ultragenyx Pharmaceutical Inc. Profile Avatar - Palmy Investing

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internat…

Biotechnology
US, Novato [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Ultragenyx Pharmaceutical Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of RARE's Analysis
CIK: 1515673 CUSIP: 90400D108 ISIN: US90400D1081 LEI: - UEI: -
Secondary Listings
RARE has no secondary listings inside our databases.